Oramed PharmaceuticalsORMP
那斯達克 · USD
4.70
+0.01
(+0.21%)
盤中 10/01 12:10 (UTC+8)
10/01 12:10 (UTC+8)
Oramed PharmaceuticalsORMP
4.70
+0.01
(+0.21%)
財務數據
損益表
- -
- -
- -
- -
- 0.02
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | - | - | - | - | - | 2,000 | - | - | - | - |
營業成本 | - | - | - | - | - | 1,987 | - | - | - | - |
營業毛利 | - | - | - | - | - | 13 | - | - | - | - |
營業費用 | 2,766 | 3,659 | 5,672 | 2,427 | 2,489 | 4,513 | 3,595 | 3,089 | 3,135 | 2,962 |
研發費用 | - | 1,594 | 1,988 | 1,153 | 1,034 | 2,206 | 1,461 | 2,242 | 1,442 | 1,179 |
推銷及管理費用 | 2,766 | 2,065 | 3,684 | 1,274 | 1,455 | 2,307 | 2,134 | 847 | 1,693 | 1,783 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -2,766 | -3,659 | -5,672 | -2,427 | -2,489 | -4,500 | -3,595 | -3,089 | -3,135 | -2,962 |
其他收入及費用 | 149,202 | 8,250 | 293 | -12,400 | 13,065 | - | -2,286 | - | - | 5,088 |
利息費用 | - | - | - | - | - | - | - | - | 261 | 592 |
稅前純益 | 101,587 | 49,440 | 9,797 | 59,451 | 13,134 | -7,058 | -9,783 | -18,509 | 10,838 | 1,534 |
所得稅 | 23,431 | 11,130 | -212 | 11,062 | -126 | 584 | 416 | 1,133 | 1,634 | - |
稅後純益 | 78,156 | 38,310 | 9,975 | 48,423 | 13,288 | -7,642 | -10,232 | -19,619 | 9,212 | 1,536 |
基本每股稅後盈餘(元) | 1.90 | 0.94 | - | 1.16 | 0.32 | -0.19 | -0.26 | -0.48 | 0.22 | 0.04 |
稀釋每股稅後盈餘(元) | 1.85 | 0.91 | 0.24 | 1.13 | 0.32 | -0.19 | -0.26 | -0.48 | 0.22 | 0.04 |
基本平均股數(千股) | 41040.00 | 40773.00 | - | 41756.00 | 41743.00 | 41228.00 | 40623.00 | 40896.00 | 40959.00 | 40835.00 |
稀釋平均股數(千股) | 42501.00 | 41970.00 | - | 42774.00 | 42609.00 | 41228.00 | 39262.00 | 40896.00 | 41591.00 | 41564.00 |
還原基本每股稅後盈餘(元) | 1.90 | 0.94 | - | 1.16 | 0.32 | -0.19 | -0.26 | -0.48 | 0.22 | 0.04 |
還原稀釋每股稅後盈餘(元) | 1.85 | 0.91 | 0.24 | 1.13 | 0.32 | -0.19 | -0.26 | -0.48 | 0.22 | 0.04 |
還原基本平均股數(千股) | 41,040 | 40,773 | - | 41,756 | 41,743 | 41,228 | 40,623 | 40,896 | 40,959 | 40,835 |
還原稀釋平均股數(千股) | 42,501 | 41,970 | - | 42,774 | 42,609 | 41,228 | 39,262 | 40,896 | 41,591 | 41,564 |
EBITDA(千元) | 101,618 | 49,470 | 9,793 | 59,516 | 13,192 | -7,028 | -9,785 | -18,434 | 11,161 | 2,184 |